Related references
Note: Only part of the references are listed.First Report on a Hyperepidemic Clone of KPC-3-Producing Klebsiella pneumoniae in Israel Genetically Related to a Strain Causing Outbreaks in the United States
Shiri Navon-Venezia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Changing Epidemiology of Antimicrobial-Resistant Streptococcus pneumoniae in the United States, 2004-2005
Sandra S. Richter et al.
CLINICAL INFECTIOUS DISEASES (2009)
Potency of SMP-601, a novel carbapenem, in hematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus
Rie Kihara et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp.
Laurent Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States
Deborah C. Draghi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Spread of OXA-48-Positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey
Amelie Carrer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents
Martti Vaara et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America
Brad Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2008)
Acinetobacter baumannii:: Emergence of a successful pathogen
Anton Y. Peleg et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives
Matthew E. Falagas et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Current challenges in treating MRSA: what are the options?
Natasha V. D. V. Ratnaraja et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
Implementation of an industrial systems-engineering approach to reduce the incidence of methicillin-resistant Staphylococcus aureus infection
Robert R. Muder et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Future directions with daptomycin
David M. Livermore
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Linkage of acquired quinolone resistance (qnrS1) and metallo-β-lactamase (blaVIM-1) genes in multiple species of Enterobacteriaceae from Bolzano, Italy
Richard Aschbacher et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland
Helen M. Palmer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06
Derek F. J. Brown et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests
Athanassios Tsakris et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06
Russell Hope et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum β-lactamases and carbapenemases
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Impact of conjugate pneumococcal vaccines on antibiotic resistance
Ron Dagan et al.
LANCET INFECTIOUS DISEASES (2008)
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Marie-Helene Nicolas-Chanoine et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia:: a systematic review and meta-analysis
Mitchell J. Schwaber et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Resistance mechanisms of multiresistant pseudomonas aeruginosa strains from Germany and correlation with Hypermutationdel
B. Henrichfreise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Carbapenemases:: the versatile β-lactamases
Anne Marie Queenan et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Activity of faropenem against cephalosporin-resistant Enterobacteriaceae
Shazad Mushtaq et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory
Neil Woodford et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
In vitro and in vivo activities of a new cephalosporin, FR264205, against Pseudomonas aeruginosa
Shinobu Takeda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
CTX-M: changing the face of ESBLs in Europe
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Bacteremia due to extended-spectrum β-lactamase producing Escherichia coli in the CTX-M era:: A new clinical challenge
Jesus Rodriguez-Bano et al.
CLINICAL INFECTIOUS DISEASES (2006)
Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media
Robert Cohen et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Occurrence of carbapenern-resistant Acinetobacter baumannii clones at multiple hospitals in London and southeast England
Juliana M. Coelho et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Detection of extended-spectrum β-lactamases in clinical isolates of Pseudomonas aeruginosa
Xiaofei Jiang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40
Karen Lolans et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict
Jane F. Turton et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
JF Turton et al.
FEMS MICROBIOLOGY LETTERS (2006)
Activity of mecillinam against ESBL producers in vitro
K Thomas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp.
F Kolayli et al.
FEMS MICROBIOLOGY LETTERS (2005)
Antimicrobial resistance in developing countries. Part I: recent trends and current status
IN Okeke et al.
LANCET INFECTIOUS DISEASES (2005)
Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY:: molecular epidemiology and in vitro activity of polymyxin B and other agents
S Bratu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom
JF Turton et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Activity of ertapenem against Neisseria gonorrhoeae
DM Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula
GJ Da Silva et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK
N Woodford et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase
AC Gales et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
CG Whitney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare?
DM Livermore
CLINICAL INFECTIOUS DISEASES (2002)
Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase
G Cornaglia et al.
CLINICAL INFECTIOUS DISEASES (2000)
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection
A Oliver et al.
SCIENCE (2000)
Share Paper
